drugset / Trial / NCT06354712

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

NCT06354712

Phase 2 Recruiting 50 enrolled Mansoura University
RandomizedParallel-groupDouble-blindPrevention

Summary

A prospective, randomized, controlled, parallel clinical trial will be conducted at Clinical Oncology and Nuclear Medicine Center at Mansoura University Hospital to assess the efficacy of N-acetylcysteine in the prevention of radiotherapy induced oral mucositis in Head and Neck cancer patients.

Timeline

Start
2024-04-04
Primary completion
2025-03-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule
Background Benzydamine Unknown

Indications